Azelis Corporate Services NV (AZE)

Currency in EUR
12.07
+0.03(+0.25%)
Closed·
AZE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.9412.16
52 wk Range
6.8813.66
Key Statistics
Prev. Close
12.04
Open
12
Day's Range
11.94-12.16
52 wk Range
6.88-13.66
Volume
221.82K
Average Volume (3m)
366.02K
1-Year Change
-6.7954%
Book Value / Share
11.65
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AZE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.73
Upside
+13.74%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

8 Buy
6 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13.73
(+13.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Hold13.00+7.71%12.00Maintain14/08/2026
Deutsche Bank
Buy14.70+21.79%14.20Maintain12/08/2026
UBS
Hold12.00-0.58%11.00Maintain11/08/2026
Kepler Cheuvreux
Hold10.50-13.01%7.50Upgrade24/06/2026
Morgan Stanley
Hold12.00-0.58%10.50Maintain15/05/2026

Azelis Corporate Services NV Earnings Call Summary for Q2/2026

  • Azelis returned to organic growth in Q2 2026 with revenue up 4%, marking first positive growth in over a year; H1 revenue reached €2.2B, up 3.2%.
  • Q2 adjusted EBITDA surged 12% YoY and 23% sequentially to support full-year positive EBITDA growth guidance; gross margin improved to 24.2%.
  • Regional performance varied: APAC led with 13% Q2 growth, Americas rose 2.3%, while EMEA declined 4.6% amid weak life sciences demand.
  • Free cash flow fell to €122M with 52.3% conversion vs 63.8% prior year; net debt stood at €1.6B with 3.4x leverage, targeting reduction by year-end.
  • Management expects Q3 conditions similar to or better than Q2, though inventory margin benefits may fade as stock reprices at higher supplier costs.
Last Updated: 30/07/2026, 05:48 pm
Read Full Transcript

Earnings

Latest Release
30/07/2026
EPS / Forecast
0.35 / --
Revenue / Forecast
1.13B / 1.11B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.46%
Dividend Yield
1.31%
Industry Median 1.92%
Annualised payout
0.16
Paid annually
5-Years Growth
-
Growth Streak

AZE Income Statement

Compare AZE to Peers and Sector

Metrics to compare
AZE
Peers
Sector
Relationship
P/E Ratio
26.0x20.8x12.1x
PEG Ratio
−0.790.200.03
Price/Book
1.0x2.0x1.4x
Price / LTM Sales
0.7x1.1x1.2x
Upside (Analyst Target)
16.0%4.4%25.0%
Fair Value Upside
Unlock10.2%7.4%Unlock

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
117.20M48.17%1.41B
Other Institutional Investors
44.08M18.12%532.09M
Public Companies & Retail Investors
82.04M33.72%990.17M
Total
243.32M100.00%2.94B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
First Pacific Advisors, LP12.14%29,548,906356,655
Invesco Ltd.10.59%25,759,400310,916

People Also Watch

82.45
SYENS
+2.81%
108.30
CAPP
+2.17%
47.42
APAM
-1.17%
26.34
SOLB
+0.53%
212.30
UCB
-3.10%

FAQ

What Is the Azelis (AZE) Stock Price Today?

The Azelis stock price today is 12.07 EUR.

What Stock Exchange Does Azelis Trade On?

Azelis is listed and trades on the Brussels Stock Exchange.

What Is the Stock Symbol for Azelis?

The stock symbol for Azelis is "AZE."

Does Azelis Pay Dividends? What’s The Current Dividend Yield?

The Azelis dividend yield is 1.31%.

What Is the Azelis Market Cap?

As of today, Azelis market cap is 2.94B EUR.

What Is Azelis's Earnings Per Share (TTM)?

The Azelis EPS (TTM) is 0.46.

When Is the Next Azelis Earnings Date?

Azelis will release its next earnings report on 22/10/2026.

From a Technical Analysis Perspective, Is AZE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Azelis Stock Split?

Azelis has split 0 times.

How Many Employees Does Azelis Have?

Azelis has 4000 employees.

What is the current trading status of Azelis (AZE)?

As of 16/08/2026, Azelis (AZE) is trading at a price of 12.07 EUR, with a previous close of 12.04 EUR. The stock has fluctuated within a day range of 11.94 EUR to 12.16 EUR, while its 52-week range spans from 6.88 EUR to 13.66 EUR.

What Is Azelis (AZE) Price Target According to Analysts?

The average 12-month price target for Azelis is 13.73 EUR, with a high estimate of 16 EUR and a low estimate of 10 EUR. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +13.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.